Sign up free to see prices on this bond
Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.
About this bond
AI BRIEF · GROUNDED IN STRUCTURED DATAGilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Gilead is a member of the Nasdaq-100 and the S&P 100.
Source: Wikipedia →Risk analytics
SEMI-ANNUAL · BULLET · PAR 100Price history
Sherpa Signal
AS OF 2026-05-01Institutional footprint · signal-level holdings
Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.
RFQ routing · coming soon
Security details
VIA OPENFIGIIssuer curve
GILD · 10 PTSYield (%) plotted against years-to-maturity. This bond highlighted in amber.
Bonds like this
HEURISTICSame currency & sector, maturity within 7 years. Ranked by overlapping institutional owners, issuer match, and rating distance.